Bas Schouwenberg

597 total citations
31 papers, 397 citations indexed

About

Bas Schouwenberg is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Infectious Diseases. According to data from OpenAlex, Bas Schouwenberg has authored 31 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 7 papers in Infectious Diseases. Recurrent topics in Bas Schouwenberg's work include Diabetes Management and Research (8 papers), HIV/AIDS drug development and treatment (7 papers) and Pancreatic function and diabetes (6 papers). Bas Schouwenberg is often cited by papers focused on Diabetes Management and Research (8 papers), HIV/AIDS drug development and treatment (7 papers) and Pancreatic function and diabetes (6 papers). Bas Schouwenberg collaborates with scholars based in Netherlands, United States and United Kingdom. Bas Schouwenberg's co-authors include David M. Burger, Bastiaan E. de Galan, Angela Colbers, Paul Smits, Dick F. Stegeman, Jeffrey Statland, Willem Woertman, Robert C. Griggs, Bas C. Stunnenberg and Gea Drost and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Neurology.

In The Last Decade

Bas Schouwenberg

28 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bas Schouwenberg Netherlands 13 109 90 74 68 58 31 397
Magnus Hillman Sweden 16 173 1.6× 150 1.7× 124 1.7× 22 0.3× 99 1.7× 46 552
Osemwegie Emovon United States 9 57 0.5× 80 0.9× 43 0.6× 42 0.6× 48 0.8× 21 313
Rossana Colla Italy 11 79 0.7× 24 0.3× 24 0.3× 28 0.4× 37 0.6× 28 334
Zixin Cai China 13 141 1.3× 85 0.9× 44 0.6× 123 1.8× 86 1.5× 28 456
Paul Hinton United Kingdom 11 100 0.9× 59 0.7× 33 0.4× 23 0.3× 177 3.1× 23 470
G Rizzo Italy 12 93 0.9× 228 2.5× 81 1.1× 12 0.2× 59 1.0× 38 527
Christian D. Lates United States 7 83 0.8× 105 1.2× 36 0.5× 19 0.3× 37 0.6× 10 387
Inga Peter United States 12 48 0.4× 65 0.7× 43 0.6× 14 0.2× 58 1.0× 17 374
Sheng-Yuan Hsiao Taiwan 13 57 0.5× 64 0.7× 15 0.2× 25 0.4× 100 1.7× 31 523
Xiaoyun Fan China 11 63 0.6× 79 0.9× 10 0.1× 148 2.2× 131 2.3× 27 514

Countries citing papers authored by Bas Schouwenberg

Since Specialization
Citations

This map shows the geographic impact of Bas Schouwenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bas Schouwenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bas Schouwenberg more than expected).

Fields of papers citing papers by Bas Schouwenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bas Schouwenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bas Schouwenberg. The network helps show where Bas Schouwenberg may publish in the future.

Co-authorship network of co-authors of Bas Schouwenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bas Schouwenberg. A scholar is included among the top collaborators of Bas Schouwenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bas Schouwenberg. Bas Schouwenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mackenzie, Isla S., Marcel Flendrie, Călin D. Popa, et al.. (2025). Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study. European Journal of Preventive Cardiology. 33(5). 682–690.
2.
3.
Pol, Marjolein van de, et al.. (2025). It takes a village: an ethnographic study on how undergraduate medical students use each other to learn clinical reasoning in the workplace. Advances in Health Sciences Education. 30(5). 1453–1471. 2 indexed citations
4.
Bon, Arianne C. van, Gozewijn D. Laverman, A. H. L. Mulder, et al.. (2024). Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands. The Lancet Digital Health. 6(4). e272–e280. 13 indexed citations
5.
Schouwenberg, Bas, et al.. (2023). Fall in prevalence of impaired awareness of hypoglycaemia in individuals with type 1 diabetes. Diabetic Medicine. 40(4). e15042–e15042. 8 indexed citations
6.
Schouwenberg, Bas, et al.. (2023). The influence of a digital clinical reasoning test on medical student learning behavior during clinical clerkships. Advances in Health Sciences Education. 29(3). 935–947.
7.
Pol, Marjolein van de, et al.. (2022). Learning clinical reasoning in the workplace: a student perspective. BMC Medical Education. 22(1). 19–19. 18 indexed citations
8.
Schouwenberg, Bas, Marieke J. H. Coenen, Andrew D. Paterson, et al.. (2017). Genetic determinants of impaired awareness of hypoglycemia in type 1 diabetes. Pharmacogenetics and Genomics. 27(9). 323–328. 9 indexed citations
9.
Stunnenberg, Bas C., Willem Woertman, Joost Raaphorst, et al.. (2015). Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol. BMC Neurology. 15(1). 43–43. 18 indexed citations
10.
Beek, Michiel van, et al.. (2015). Pharmacokinetic Drug–Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(1). 44–51. 11 indexed citations
11.
Colbers, Angela, et al.. (2015). Pharmacokinetic Drug–drug Interaction Study between Raltegravir and Citalopram. Antiviral Therapy. 21(2). 143–152. 6 indexed citations
12.
Colbers, Angela, et al.. (2014). Effect of fosamprenavir/ritonavir on the pharmacokinetics of single-dose olanzapine in healthy volunteers. International Journal of Antimicrobial Agents. 44(2). 173–177. 17 indexed citations
13.
Wissen, C.P.W.G.M. Verwey-van, et al.. (2013). Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole. Journal of Antimicrobial Chemotherapy. 68(6). 1415–1422. 4 indexed citations
14.
15.
Schouwenberg, Bas, Paul Smits, Cees J. Tack, & Bastiaan E. de Galan. (2011). The effect of antecedent hypoglycaemia on β2-adrenergic sensitivity in healthy participants with the Arg16Gly polymorphism of the β2-adrenergic receptor. Diabetologia. 54(5). 1212–1218. 6 indexed citations
16.
Luin, Matthijs van, et al.. (2010). Drug-Drug Interactions Between Raltegravir and Pravastatin in Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 82–86. 12 indexed citations
17.
Brüggemann, Roger J. M., et al.. (2010). Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers. Journal of Antimicrobial Chemotherapy. 65(10). 2188–2194. 14 indexed citations
18.
Schouwenberg, Bas, B. A. J. Veldman, Wilko Spiering, et al.. (2008). The Arg16Gly variant of the β2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus. Pharmacogenetics and Genomics. 18(4). 369–372. 9 indexed citations
19.
Schouwenberg, Bas, Saskia J. Rietjens, Paul Smits, & Bastiaan E. de Galan. (2006). Effect of Sex on the Cardiovascular Response to Adrenaline in Humans. Journal of Cardiovascular Pharmacology. 47(1). 155–157. 7 indexed citations
20.
Driessen, Gertjan J. A., et al.. (2002). Sulphadoxine/pyrimethamine: an appropriate first‐line alternative for the treatment of uncomplicated falciparum malaria in Ghanaian children under 5 years of age. Tropical Medicine & International Health. 7(7). 577–583. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magnus Hillman Breakdown of academic impact, for papers by Osemwegie Emovon Breakdown of academic impact, for papers by Rossana Colla Breakdown of academic impact, for papers by Zixin Cai Breakdown of academic impact, for papers by Paul Hinton Breakdown of academic impact, for papers by G Rizzo Breakdown of academic impact, for papers by Christian D. Lates Breakdown of academic impact, for papers by Inga Peter Breakdown of academic impact, for papers by Sheng-Yuan Hsiao Breakdown of academic impact, for papers by Xiaoyun Fan
Rankless by CCL
2026